Our Services
Medical Information
Helpful Resources
Published on: 10/22/2026
Blood thinners are typically stopped about 1 to 7 days before surgery, with the exact timing depending on the specific drug, your kidney function, and your bleeding and clotting risk: warfarin is usually held about 5 days, direct oral anticoagulants such as apixaban, rivaroxaban, or dabigatran about 1 to 3 days, and antiplatelet drugs like clopidogrel or aspirin roughly 5 to 7 days. Some people are given "bridging" injections of heparin or enoxaparin during the gap, while others with low clot risk or minor procedures may not need to stop at all. There are several important factors to consider, including when to restart the medication after surgery, so see below to understand more before changing anything on your own.
If you are unsure how your medication, procedure type, or health history fit together, a free, instant, online symptom check can help you organize what you are experiencing and what to ask your surgeon or prescriber. It takes only a few minutes, works on any device, and gives you clearer language for next steps, which matters because stopping a blood thinner too early raises stroke and clot risk while stopping too late raises surgical bleeding risk.
Last reviewed for medical accuracy: 10/22/2026
Stopping blood thinners before surgery is a common concern. Proper timing helps reduce bleeding risks while keeping you safe from clots. Below, we explain typical guidelines and factors that affect how many days to stop blood thinners before surgery. Remember, every person and procedure is different—always speak to your doctor for personalized advice.
Blood thinners (anticoagulants and antiplatelets) lower your risk of dangerous clots but also raise bleeding risk. If you stop too soon, you may face clotting issues. If you stop too late, you could bleed heavily during or after your operation.
Key goals when you stop blood thinners before surgery:
Below are usual recommendations. These can vary based on your kidney function, the type of surgery, and your personal clotting risk.
These include apixaban (Eliquis), rivaroxaban (Xarelto), dabigatran (Pradaxa) and edoxaban (Savaysa).
These thin the blood by preventing platelets from clumping. Common types include aspirin, clopidogrel (Plavix), prasugrel (Effient) and ticagrelor (Brilinta).
For some high‐risk patients (e.g., those with mechanical heart valves, recent clot, atrial fibrillation with high CHA₂DS₂-VASc score), your doctor may suggest “bridging.” This means stopping warfarin but using short‐acting heparin until shortly before your surgery.
Bridging lowers clot risk but slightly increases bleeding risk. Your surgeon, hematologist or cardiologist will determine if it’s right for you.
Restarting depends on your bleeding risk after surgery:
Your team will balance clot vs. bleeding risk. They may restart a lower dose first or use heparin bridging until you can safely take your usual medication.
It’s normal to have questions or concerns about stopping and restarting blood thinners. If you notice unusual symptoms—such as severe bleeding, new swelling, chest pain or sudden shortness of breath—seek medical attention right away.
You might also consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It’s an easy way to see what might be going on before you talk to your doctor:
free, online symptom check, using the doctor approved Ubie Symptom Checker
Stopping blood thinners at the right time strikes a balance between bleeding and clotting risks. These guidelines are a starting point; they are not a substitute for professional advice. If you have any serious or life‐threatening concerns, please speak to a doctor immediately. Always follow the guidance of your healthcare team when preparing for surgery.
(References)
* Ickx BE. New anticoagulant drugs: monitoring and perioperative strategies. Acta Anaesthesiol Belg. 2006;57(4):409-18. PMID: 17236644.
* Wamala H, Scott IA, Caney X. Perioperative management of new oral anticoagulants in patients undergoing elective surgery at a tertiary hospital. Intern Med J. 2017 Dec;47(12):1412-1421. doi: 10.1111/imj.13513. PMID: 28589690.
* Barnes GD, Mouland E. Peri-Procedural Management of Oral Anticoagulants in the DOAC Era. Prog Cardiovasc Dis. 2018 Mar-Apr;60(6):600-606. doi: 10.1016/j.pcad.2018.03.002. Epub 2018 Mar 10. PMID: 29534986; PMCID: PMC5972056.
* Nazha B, Pandya B, Cohen J, Zhang M, Lopes RD, Garcia DA, Sherwood MW, Spyropoulos AC. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation. Circulation. 2018 Oct 2;138(14):1402-1411. doi: 10.1161/CIRCULATIONAHA.117.031457. PMID: 29794081.
* Lamperti M, Khozenko A, Kumar A. Perioperative Management of Patients Receiving New Anticoagulants. Curr Pharm Des. 2019;25(19):2149-2157. doi: 10.2174/1381612825666190709220449. PMID: 31560280.
* Talari G, Demertzis ZD, Summey RD, Gill B, Kaatz S. Perioperative management of anticoagulation. Hosp Pract (1995). 2020 Dec;48(5):231-240. doi: 10.1080/21548331.2020.1792138. Epub 2020 Jul 13. PMID: 32627607.
* Josef AP, Garcia NM. Systemic Anticoagulation and Reversal. Surg Clin North Am. 2022 Feb;102(1):53-63. doi: 10.1016/j.suc.2021.09.011. PMID: 34800389.
* Nielsen JD, Hermann TS, Husum D, Osbak PS. [Perioperative heparin bridging is rarely indicated]. Ugeskr Laeger. 2021 Nov 22;183(47). PMID: 34851259.
* Retrouvey H, Ipaktchi K, Lauder A. Evidence-based postoperative replantation protocols. Eur J Orthop Surg Traumatol. 2024 Oct;34(7):3699-3705. doi: 10.1007/s00590-023-03706-8. Epub 2023 Aug 28. PMID: 37639003.
* Schirmer SH. [Cardiovascular management of patients undergoing noncardiac surgery]. Herz. 2024 Dec;49(6):479-488. doi: 10.1007/s00059-024-05274-x. Epub 2024 Oct 21. PMID: 39432064.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.